Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery
Life · 25.09.2025 · 15 (10) · 1508
DOI: 10.3390/life15101508 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 25.09.2025. Verfasst von Moncef Al Barajraji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hôpital Universitaire de Bruxelles, Université Libre Bruxelles, 1070 Brussels, Belgium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer (PCa) diagnosis has historically relied on the prostate-specific antigen (PSA) testing. Although the screening significantly reduces mortality rates, PSA has low specificity with risks of overdiagnosis and overtreatment. These limitations highlight the need for a more accurate diagnostic approach. Emerging technologies, such as artificial intelligence (AI), novel biomarkers, and advanced imaging techniques, offer promising avenues to enhance the accuracy and efficiency of PCa diagnosis and risk stratification. This narrative review comprehensively analyzed the current literature, focusing on new tools aiding PCa diagnosis (AI-driven image interpretation, radiomics, genomic classifiers, biomarkers, and multimodal data integration) with consideration for technical, regulatory, and ethical challenges related to clinical implementation of AI-based technologies. A literature search was performed using the PubMed and MEDLINE databases to identify relevant peer-reviewed articles published in English using the search terms “prostate cancer,” “artificial intelligence,” “machine learning,” “deep learning,” “MRI,” “histopathology,” and “diagnosis.” Articles were selected based on their relevance to AI-assisted diagnostic tools, clinical utility, and performance metrics. In addition, a separate section was developed initially to contextualize the limitations of current PSA-based screening approaches. The reviewed studies showed that AI had significant utility in prostate mpMRI interpretation (lesion detection; Gleason grading) with high accuracy and high reproducibility. For the pathologist, AI-driven algorithms improve the diagnostic accuracy of digital slide evaluation for histologic diagnosis of prostate cancer and automated Gleason score grading. Genomic tools such as the Oncotype DX test, combined with AI, could also allow for tailored and individualized risk prediction. Overall, multimodal models integrating clinical, imaging, and molecular data often outperform traditional PSA-based strategies and reduce unnecessary biopsies. Transition from PSA-centered toward AI-driven, biomarker-supported, and image-enhanced diagnosis marks a critical evolution in PCa diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Hôpital Universitaire de Bruxelles, Université Libre Bruxelles, 1070 Brussels, Belgium.
- Department of Urology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre 91509-900, Brazil.
- Department of Urology, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, 28040 Madrid, Spain.
- Department of Urology, Universidad Complutense de Madrid, 28015 Madrid, Spain.
ORCID-Profile: Mathieu Coscarella, Ilyas Svistakov, Isabel Galante, Juan Gómez Rivas, Jesús Moreno Sierra
Zitieren
APA
Al Barajraji, M., Coscarella, M., Svistakov, I., Flôres Soares da Silva, H., Déniz, P. M., Marugan, M. J., González-Santander, C., Fernández Montarroso, L., Galante, I., Rivas, J. G., & Moreno Sierra, J. (2025). Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery. Life, 15(10), 1508. https://doi.org/10.3390/life15101508
Vancouver
Al Barajraji M, Coscarella M, Svistakov I, Flôres Soares da Silva H, Déniz PM, Marugan MJ, et al. Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery. Life. 2025;15(10):1508. doi:10.3390/life15101508
BibTeX
@article{AlBarajraji2025,
author = {Al Barajraji, Moncef and Coscarella, Mathieu and Svistakov, Ilyas and Flôres Soares da Silva, Helena and Déniz, Paula Mata and Marugan, María Jesús and González-Santander, Claudia and Fernández Montarroso, Lorena and Galante, Isabel and Rivas, Juan Gómez and Moreno Sierra, Jesús},
title = {Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery},
journal = {Life},
year = {2025},
volume = {15},
number = {10},
pages = {1508},
doi = {10.3390/life15101508}
}
EUVIMED